Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells

Bone Marrow Transplantation

Volumn 26, Issue 7, 2000, Pages 797-800

  Higman, M A ^a   Port, J D ^a   Beauchamp Jr , N J ^a   Chen, A R ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

DMSO; Leukoencephalopathy; MRI; Reversible; Stem cell infusion

Indexed keywords

AMIKACIN; AMPHOTERICIN B CHOLESTEROL SULFATE; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIMETHYL SULFOXIDE; DIPHENHYDRAMINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; FOSPHENYTOIN SODIUM; FUROSEMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROMORPHONE; IFOSFAMIDE; ISOPRENALINE; LORATADINE; MYELOABLATIVE AGENT; ONDANSETRON; PIPERACILLIN PLUS TAZOBACTAM; RANITIDINE; VANCOMYCIN; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN ATROPHY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CRYOPRESERVATION; CYTAPHERESIS; DISORIENTATION; EWING SARCOMA; FEMALE; HUMAN; HYPOTHERMIA; INFUSION; LEUKOENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SOMNOLENCE; STEM CELL; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; WHITE MATTER;

EID: 0033764618     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702589     Document Type: Article

References (17)

1. A reversible posterior leukoencephalopathy syndrome
2. Hypertensive encephalopathy: Findings on CT, MR imaging, and SPECT imaging in 14 cases
3. Cranial magnetic imaging in severe pre-eclampsia vs eclampsia
4. Neurologic complications in allogenic bone marrow transplant patients receiving cyclosporine
5. Immunosuppression-induced leukoencephalopathy from tacrolimus
6. Reversible encephalopathy after cryopreserved peripheral stem cell infusion
7. The metabolism of dimethyl sulfoxide and its metabolic effects in man and animals
8. Dimethylsulphoxide-induced toxicity
9. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplants
10. Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders
11. Indications and contraindications for the use of DMSO in clinical dermatology
12. The single and repeated dose toxicity of dimethyl sulfoxide
13. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases
14. Clinical toxicity of cryopreserved circulating progenitor cells infusion
15. Reversible intracerebral pathological entities mediated by vascular autoregulatory dysfunction
16. Posterior leukoencephalopathy may not be reversible
17. Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids